Alendronate Sodium Tablets
Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- SPE2D2-25-R-0023
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Not on record
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical is planning to issue a solicitation for a national requirements contract to procure Alendronate Sodium Tablets in two strengths: 35 mg tablets in 4-count boxes and 70 mg tablets in 4-count boxes, with each box containing one card of 4 blister tablets. This procurement will establish a national supply source to serve Department of Defense and Indian Health Service customers through the DLA and VA prime vendor programs. The acquisition will be unrestricted and fully competitive, with all sources eligible to submit proposals for consideration. The contract structure will be a firm-fixed price requirements-type contract featuring a one-year base period and four one-year option periods. The solicitation is projected for release in October 2025, though DLA reserves the right to issue it before or after this date, and interested parties should contact Courtney Hunter-Stangler at Courtney.Hunter-Stangler@dla.mil with questions.
This procurement opportunity does not utilize any set-aside designations, making it available to all eligible contractors regardless of size or socioeconomic status. No current contractors or incumbents are identified in the pre-solicitation notice. The contract will span a potential five-year period when including all option years, though specific award values or budget ranges are not disclosed in this initial notice. Annual usage estimates will be provided in the Schedule of Supplies section when the formal solicitation is released. The procurement falls under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and PSC code 6505 (Drugs and Biologicals), indicating the specialized nature of this pharmaceutical supply contract.
Notice text
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Alendronate Sodium Tablets. Procurement details follow.
Alendronate Sodium: 35 MG Tablets in 4 count boxes and 70 MG Tablets in 4 count boxes. (1 card of 4 blister tablets per box).
This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense and Indian Health Service customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://sam.gov. Interested parties should contact Courtney Hunter-Stangler at Courtney.Hunter-Stangler@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is October of 2025. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Alendronate Sodium Tablets | Award Notice | |
| Alendronate Sodium Tablets | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity